EPM2AIP1 anticorps (C-Term)
Aperçu rapide pour EPM2AIP1 anticorps (C-Term) (ABIN5672140)
Antigène
Voir toutes EPM2AIP1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Séquence
- EKAFSYLTRN QHTLSQPLTD EHLQALFRVA TTEMEPGWDD LVRERNESNP
-
Purification
- Affinity purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the C terminal region of human EPM2AIP1
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- EPM2AIP1 (EPM2A (Laforin) Interacting Protein 1 (EPM2AIP1))
-
Autre désignation
- EPM2AIP1
-
Sujet
-
The EPM2A gene, which encodes laforin, is mutated in an autosomal recessive form of adolescent progressive myoclonus epilepsy. The protein encoded by this gene binds to laforin, but its function is not known. This gene is intronless.
Protein Size: 607 -
ID gène
- 9852
-
NCBI Accession
- NM_014805, NP_055620
-
UniProt
- Q7L775
Antigène
-